Analysis of Plasmodium vivax hexose transporters and effects of a parasitocidal inhibitor
- 27 July 2004
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 381 (3) , 905-909
Abstract
Plasmodium vivax is the second most common species of malaria parasite and causes up to 80 million episodes of infection each year. New drug targets are urgently needed because of emerging resistance to current treatments. To study new potential targets, we have functionally characterized two natural variants of the hexose transporter of P. vivax (PvHT) after heterologous expression in Xenopus oocytes. We show that PvHT transports both glucose and fructose. Differences in the affinity for fructose between the two variants of PvHT establishes that sequence variation is associated with phenotypic plasticity. Mutation of a single glutamine residue, Gln167, predicted to lie in transmembrane helix 5, abolishes fructose transport by PvHT, although glucose uptake is preserved. In contrast, the exofacial site located between predicted helices 5 and 6 of PvHT is not an important determinant of substrate specificity, despite exhibiting sequence polymorphisms between hexose transporters of different Plasmodium spp. Indeed, replacement of twelve residues located within this region of PvHT by those found in the orthologous Plasmodium falciparum sequence (PfHT) is functionally silent with respect to affinity for hexoses. All PvHT variants are inhibited by compound 3361, a long-chain O-3 derivative of D-glucose effective against PfHT. Furthermore, compound 3361 kills short term cultures of P. vivax isolated from patients. These data provide unique insights into the function of hexose transporters of Plasmodium spp. as well as further evidence that they could be targeted by drugs.Keywords
This publication has 17 references indexed in Scilit:
- Why is the Plasmodium falciparum hexose transporter a promising new drug target?Expert Opinion on Therapeutic Targets, 2003
- Case reports: pernicious complications of benign tertian malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 2003
- Validation of the hexose transporter of Plasmodium falciparum as a novel drug targetProceedings of the National Academy of Sciences, 2003
- Novel Point Mutations in the Dihydrofolate Reductase Gene of Plasmodium vivax : Evidence for Sequential Selection by Drug PressureAntimicrobial Agents and Chemotherapy, 2003
- Simple In Vitro Assay for Determining the Sensitivity of Plasmodium vivax Isolates from Fresh Human Blood to Antimalarials in Areas where P. vivax Is EndemicAntimicrobial Agents and Chemotherapy, 2003
- Comparative characterization of hexose transporters of Plasmodium knowlesi, Plasmodium yoelii and Toxoplasma gondii highlights functional differences within the apicomplexan familyBiochemical Journal, 2002
- Mutational Analysis of the Hexose Transporter of Plasmodium falciparum and Development of a Three-dimensional ModelJournal of Biological Chemistry, 2002
- Malaria in 2002Nature, 2002
- Hexose Transport in Asexual Stages of Plasmodium falciparum and KinetoplastidaeParasitology Today, 2000
- Hexose permeation pathways in Plasmodium falciparum -infected erythrocytesProceedings of the National Academy of Sciences, 2000